Four things to know:
1. In 2019, the market was valued at $1.1 billion.
2. A rise in approvals and product launches is expected to boost the market during the forecast period.
3. Recent developments in the market include Centinel Spine gaining FDA approval for a two-level clinical trial of its Prodisc C anterior cervical total disc devices and Zimmer Biomet launching its Mobi-C cervical disc in Japan.
4. Ongoing clinical trials for the treatment of degenerative disc disease is contributing to the growth of the Asia Pacific market.
More articles on devices:
Dr. Daniel Yoshor excited by new challenge at Penn Medicine
New York neurosurgeon recovers from COVID-19, volunteers at hospital ICU
Neurosurgeon, dentist’s 3D printed masks evolved production, being made worldwide: 5 details
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
